Patents Assigned to Bioneer Corporation
  • Patent number: 8852920
    Abstract: The present invention relates to a micro-chamber plate and a manufacturing method of the same, more precisely a micro-chamber plate facilitating real-time measurement and analysis of fluorescence obtained from the reaction of multiple reaction solutions containing primers or probes selectively binding to each corresponding gene without cross-contamination in order to analyze biological samples containing numbers of genes and a manufacturing method of the same.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: October 7, 2014
    Assignee: Bioneer Corporation
    Inventors: Han Oh Park, Gu-Young Song
  • Publication number: 20140291583
    Abstract: Provided are a method for manufacturing a carbon nanotube-metal oxide composite, and a carbon nanotube-metal oxide composite manufactured thereby, the method comprising: dispersing carbon nanotubes in a reductive solvent to prepare a dispersion liquid; adding a co-reducing agent and a metal precursor to the dispersion liquid to prepare a mixture liquid; and performing heat treatment on the mixture liquid to coat the metal precursor on the carbon nanotubes in a metal oxide form, so that there can be provided a carbon nanotube-metal oxide composite where metal oxide particles of several nm to several tens of nm are uniformly dispersed in carbon nanotubes or combined with surfaces of the carbon nanotubes in a coating type.
    Type: Application
    Filed: September 26, 2012
    Publication date: October 2, 2014
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Jae Ha Kim, Kuk Jin Yun
  • Publication number: 20140212919
    Abstract: Provided is a method of protein synthesis. The method of protein synthesis according to the present invention uses an automatic biological material purification apparatus including: a well plate kit; a heating part; and a magnetic field applying part, such that a plurality of target proteins may be more quickly and simply obtained as compared to target proteins obtained by using the existing method for expressing/purifying proteins through conventional cell culture, and a reproducible synthesis efficiency on the same proteins may be obtained due to no deviation between reaction wells.
    Type: Application
    Filed: August 23, 2012
    Publication date: July 31, 2014
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, You Sang Cho, Jun Ho Jung, Ji Won Han, Nam Il Kim
  • Patent number: 8779114
    Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: July 15, 2014
    Assignee: Bioneer Corporation
    Inventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
  • Patent number: 8772472
    Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: July 8, 2014
    Assignee: Bioneer Corporation
    Inventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
  • Patent number: 8697020
    Abstract: The present invention relates to silica magnetic particles having a spherical form and a process for preparing the same. The silica magnetic particles prepared according to the present invention, which are silica particles that includes the magnetic particles and additionally have the functional group on the surfaces, has an advantage that the particle size distribution is uniform. Further, the silica magnetic particles prepared according to the present invention can be used as a reagent for separating biomaterials and a reagent for detecting biomaterials.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 15, 2014
    Assignee: Bioneer Corporation
    Inventors: Jae-Ha Kim, Jong-Gwang Park, Jong-Hoon Kim, Han-Oh Park
  • Publication number: 20140087377
    Abstract: The present invention relates to a method of identifying nucleic acid-containing object, more precisely a method of identifying nucleic acid-containing object which comprises the following steps: (1) preparing nucleic acid-containing object having the nucleotide sequence complementary to the nucleotide sequence of RNA-dual probe; (2) reacting the nucleic acid included in the object with the buffer containing the RNA-dual probe conjugated with a reporter and a quencher respectively and RNase; and (3) detecting fluorescence generated from the reporter.
    Type: Application
    Filed: March 13, 2012
    Publication date: March 27, 2014
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Jung Young Choi, Eun Su Han, Gu Young Song, Won Seok Jang
  • Publication number: 20140060400
    Abstract: This invention relates to a device for effectively removing organic compounds from air by a carbon nanotube-catalyst composite having the two functions of an adsorption/catalytic incineration agent. The carbon nanotube-catalyst composite simultaneously adsorbs the organic compounds and completely decomposes them by a catalytic reaction, and the optimal reaction active temperature by catalytic incineration is low. The carbon nanotube-catalyst composite has a large surface area and has high adsorption performance and catalytic decomposition activity, and is thus applicable to filters that use the methods of adsorption and/or catalytic incineration. The device for removing organic compounds from air includes an adsorption/catalytic incineration reactor including the carbon nanotube-catalyst composite to remove organic compounds from air.
    Type: Application
    Filed: November 24, 2011
    Publication date: March 6, 2014
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Young-Mi Koo, Jae Ha Kim, Yang Won Lee
  • Publication number: 20140045244
    Abstract: The present invention relates to a reverse transcriptase having improved thermostability, more precisely a mutant reverse transcriptase with improved thermostability by substitution of one or more amino acids selected from the group consisting of the 63rd glutamine (Q63), the 264th lysine (K264), the 295th lysine (K295), the 306th threonine (T306), the 346th glutamic acid (E346), the 408th proline (P408), the 438th histidine (H438), and the 454th asparagin (N454) of the amino acid sequence of M-MLV originated reverse transcriptase represented by SEQ. ID. NO: 1 with other amino acids. The mutant reverse transcriptase of the present invention demonstrates excellent thermostability, compared with the wild type reverse transcriptase. Therefore, it is advantageous to obtain the target cDNA with stable reverse transcription activity even in the presence of RNA that can form the stable secondary structure at a high temperature.
    Type: Application
    Filed: February 7, 2012
    Publication date: February 13, 2014
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Sung Jun Yang, Sung Mo Joo, Byoung Oh Hwang
  • Patent number: 8551426
    Abstract: Provided are an RNase activity inhibitory compound to effectively control the activity of the RNase promoting degradation of extracted RNAs and, in addition, a sample storage container including the same. The RNase activity inhibitory compound and the sample storage container according to the present invention may be effectively used to store RNAs during RNA extraction or the extracted RNAs.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: October 8, 2013
    Assignee: Bioneer Corporation
    Inventors: Jong Hoon Kim, Hwangseo Park, Han Oh Park
  • Publication number: 20130236903
    Abstract: Disclosed is an automatic nucleic acid purification apparatus which can prevent pollution due to aerosol generated from a biological sample containing high concentration target nucleic acid when the biological sample containing the high concentration target nucleic acid is mixed with other biological sample containing low concentration target nucleic acid or not containing the target nucleic acid. Further, disclosed is an automatic nucleic acid purification apparatus which can be applied to all kinds of nucleic acid purification equipments for purifying a plurality of biological samples using a magnet rode or a multi-pipette block moving in two or three axial directions, and which can minimize pollution due to the aerosol generated from the biological sample containing high concentration target nucleic acid and also can obtain accurate results.
    Type: Application
    Filed: November 18, 2011
    Publication date: September 12, 2013
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Byung Rae Jeong, Kwon Sic Kim
  • Patent number: 8530639
    Abstract: A method for isolating a nucleic acid from a biological sample includes applying particulate matter to promote co-aggregation and co-precipitation of insoluble aggregate by directly adding to the biological sample, adding to the biological sample in admixture with a cell lysis buffer, adding to the biological sample treated with a cell lysis buffer, adding to cell lysates in admixture with a buffer for forming denatured protein aggregate; or adding to cell lysates comprising the formed denatured protein aggregate. The particulate matter is selected from the group consisting of a material formed from an element of Ag, Fe, Ti, Al, Sn, Si, Cu, Mo, Ni, W or Zn, an oxide, a carbide, a nitride, a boride and a silicide thereof, and a mixture thereof, a polymer selected from PMMA (Poly Methyl MethAcrylate), polyethylene or polyurethane; and a mixture thereof. The insoluble aggregate comprises denatured protein aggregate and cell debris.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: September 10, 2013
    Assignee: Bioneer Corporation
    Inventors: Jong-Hoon Kim, Min Kim, Hae-Joon Park, Han Oh Park
  • Publication number: 20130230860
    Abstract: The present invention relates to an automatic real-time quantitative amplification system which can perform analysis of various biological samples, and more particularly to an automatic real-time quantitative amplification system in which a plurality of decks for respectively accommodating biological samples are put in a deck storing/transferring device, whereby it is possible to automatically analyze an amount or existence of a target substance containing a target nucleic acid in the biologic sample, such as a particular gene, a particular, a particular pathogenic bacterium and a particular protein, by amplifying the target nucleic acid purified by some processes of purification, purification after culture, or purification after reaction of the target substance contained in the bio-logical sample and then checking an amount of the amplified target nucleic acid.
    Type: Application
    Filed: October 27, 2011
    Publication date: September 5, 2013
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Kwon Sic Kim, Yang Won Lee, Jin II Lee, Byung Rae Jeong, Jong Hoon Kim
  • Patent number: 8513399
    Abstract: The present invention relates to primers for PCR amplification comprising abasic parts within the primer sequences and a method for PCR amplification using the same. More precisely, the present invention relates to primers capable of amplifying different templates and having abasic parts complementary to mutated site or polymorphic site of template DNA and a method for PCR amplification comprising the steps of mixing the composition for PCR amplification comprising the primers with nucleic acid template; and performing PCR with the mixture. The primers for PCR amplification of the present invention contain abasic parts not having specific coding information in their nucleotide sequences, so that they can amplify different templates having mutated sites at the same time.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: August 20, 2013
    Assignee: Bioneer Corporation
    Inventors: Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, Han Oh Park
  • Publication number: 20130210133
    Abstract: Provided is a low heat capacity composite for a thermal cycler . The low heat capacity composite of the present invention is a low heat capacity composite for a thermal cycler capable of overcoming difficulty in manufacture and reproducibility due to uniqueness of the existing PCR thermal cycler only. The low heat capacity composite of the present invention can reduce the cost of raw material and retain excellent heat property due to the improvement in low heat capacity and physical and mechanical properties, thereby remarkably shortening PCR reaction time and saving energy when used as a thermal block for a thermal cycler.
    Type: Application
    Filed: August 8, 2011
    Publication date: August 15, 2013
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Jae Ha Kim
  • Publication number: 20130157275
    Abstract: Provided are an oligonucleotide marker and a method of identifying a material using the same. The oligonucleotide marker makes it possible to analyze a trace amount of the material with high precision within a short time, has improved solubility in an oily solvent, and can improve a detection method such that the oligonucleotide marker can be detected within 2 hours. The oligonucleotide marker can label various products, including oil products and petroleum products, works of art and collections, and can also be used to conduct criminal investigations.
    Type: Application
    Filed: March 1, 2013
    Publication date: June 20, 2013
    Applicant: BIONEER CORPORATION
    Inventor: BIONEER CORPORATION
  • Publication number: 20130115686
    Abstract: The present invention relates to a micro chamber plate, and more particularly, to an analytic micro chamber plate in which a plurality of reaction solutions including a primer or probe selectively reacting with a nucleic acid react with each other without cross-contamination to measure and analyze a fluorescence level in real-time so as to analyze biological sample solution including a large amount of nucleic acids. Also, the present invention relates to a method of manufacturing the analytic chamber plate. Also, the present invention relates to a method of manufacturing a micro chamber plate with a built-in sample used for manufacturing the analytic chamber plate. Also, the present invention relates to an apparatus set for manufacturing the micro chamber plate with a built-in sample.
    Type: Application
    Filed: June 1, 2011
    Publication date: May 9, 2013
    Applicant: Bioneer Corporation
    Inventors: Han Oh Park, Gu Young Song, Jung A Bae
  • Patent number: 8427643
    Abstract: The present invention relates to a real-time PCR monitoring apparatus for real-time monitoring production of reaction product produced during the reaction while performing nucleic acid amplification such as PCR for various kinds of trace samples. Specifically, the present invention relates to an apparatus for real-time monitoring biochemical reaction for efficiently dividing interference between an excitation light and a fluorescence, which includes a polarizer, a polarizing beam splitter, a polarization converter and so on.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: April 23, 2013
    Assignee: Bioneer Corporation
    Inventors: Hanee Park, Il kyu Choi, Han Oh Park
  • Publication number: 20130096288
    Abstract: Provided are an siRNA-polymer conjugate, and a method for preparing the same, and more specifically, to a hybrid conjugate formed by covalently bonding siRNA and a polymeric compound for improving the in vivo stability of siRNA, and to a preparation method of the hybrid conjugate. The conjugate of the present invention can improve the in vivo stability of siRNA, thereby achieving an efficient delivery of therapeutic siRNA into cells and exhibiting the activity of siRNA even with a small dose of a relative low concentration. Therefore, the conjugate can advantageously be used as not only an siRNA treatment tool for cancers and other infectious disease, but also a novel type siRNA delivery system.
    Type: Application
    Filed: September 13, 2012
    Publication date: April 18, 2013
    Applicant: Bioneer Corporation
    Inventors: Bo Ram Han, Han Oh Park, Mi Sik Shin, Sam Young Lee
  • Publication number: 20130043191
    Abstract: Disclosed is an automatic purification apparatus for isolating target substances from multiple biological samples, and more particularly to an automatic biological sample purification apparatus equipped with a magnetic field applying part, in which the magnetic field applying part for purifying biological samples and a heating part are integrally formed with each other so as to be movable up and down. Further, disclosed is a method of extracting a target substance from the biological sample using the automatic biological sample purification apparatus equipped with the magnetic field applying part.
    Type: Application
    Filed: April 29, 2011
    Publication date: February 21, 2013
    Applicant: BIONEER CORPORATION
    Inventors: Han-oh Park, Jong-kab Kim, Yang-won Lee, Jong-hoon Kim